New research shows that corticosteroid injections for knee OA treatment do not hasten a patient's progression to a total knee replacement when compared with hyaluronic acid injections. Details of this ...

Approved by the Drug Controller General of India (DCGI), the treatment offers to slow disease progression and promote ...

Cipla and Stempeutics launch Ciplostem, a DCGI-approved cell therapy for Grade II–III Knee Osteoarthritis, offering long-term ...

Please provide your email address to receive an email when new articles are posted on . Use of corticosteroid injections did not exacerbate radiographic progression of knee osteoarthritis or ...

Please provide your email address to receive an email when new articles are posted on . Knee osteoarthritis accounts for about 80% of the burden of OA worldwide, and published studies show it ...

Patients with osteoarthritis (OA) primarily affecting only one knee joint compartment did just as well with partial knee replacement (PKR) as with total arthroplasty after 10 years in a randomized ...

An Osaka Metropolitan University-led research team found that patients with knee osteoarthritis show a weaker human-body ...

Biomechanical footwear calibrated for individual use demonstrated a significant improvement in the pain scores of individuals with knee osteoarthritis after 24 weeks in a recent trial. Although the ...

Ladan Nikravan Hayes, for Flexion Therapeutics, Inc. Joe West, 68, isn’t a stranger to knee pain. In high school, sports were his greatest passion — football, wrestling, golf, it didn’t matter the ...

The purpose of the current study was to characterize the gait profile of patients with knee OA compared to matched controls using a new measuring system that can be applied in clinic settings rather ...

According to the Arthritis Foundation, nearly one in three adults suffer from chronic joint pain and 21 million Americans suffer from OA, the mostcommon form of arthritis, which is characterized by a ...

A new study presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that after three months of treatment with oral methotrexate, adults with primary knee ...